CLINICAL STUDY AGREEMENT SMLOUVA O KLINICKÉM HODNOCENÍ Protocol No: H15/02 (“the Protocol”) Protokol č.: H15/02 (“Protokol”) EudraCT No: 2015-004451-40 EudraCT No: 2015-004451-40 Investigational medicinal product (“the IMP”): Tetrahydrocannabinol...
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
https://smlouvy.gov.cz/smlouva/soubor/217933/Smlouva_o_provedeni_klinickeho_hodnoceni_r.pdfUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (2)
Alternatively, you can try searching for similar contracts:
